封面
市場調查報告書
商品編碼
1566223

益智藥市場規模、佔有率、成長分析、按格式、分銷管道、按地區 - 產業預測,2024-2031

Nootropics Market Size, Share, Growth Analysis, By Form (Capsules/Tablets, Powder), By Distribution Channel (Online, Offline), By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球促智藥市場規模為37.7億美元,從2023年的43.2億美元成長到2031年的128.7億美元,預測期(2024-2031)預計複合年成長率為14.62%。

促智藥市場涵蓋各種旨在改善記憶力、創造力和注意力等心理功能的認知增強劑,並且由於各個領域的消費者需求不斷成長,該市場正在經歷顯著成長。天然和合成化合物,包括咖啡因、人參和Modafinil,透過促進大腦的血液流動、增加神經傳導物質水平和保護神經細胞健康而發揮作用,使其在這一領域發揮著極其重要的作用。然而,某些促智藥的長期影響仍不清楚,這凸顯了在醫療監督下使用這些物質的重要性。在美國,綜合維他命片也有雙重用途,因為成年人經常使用它們來改善認知功能,例如注意力和警覺性。智慧醫療的日益普及也反映在 Dualdiagnosis.org 等資訊來源報告的趨勢中,突顯了增強心理能力的社會趨勢。學生和專業人士對智慧藥物的廣泛接受進一步推動了這個市場的擴張,強調將認知增強劑納入日常生活時需要仔細考慮。總體而言,在人們對精神敏銳度和生產力提高的追求的推動下,促智藥市場是一個快速成長的領域,具有廣闊的成長機會。

目錄

介紹

  • 研究目的
  • 定義
  • 市場範圍

調查方法

  • 資訊採購
  • 二手資料來源和主要資料來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 市場概況展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 監管環境
  • 價值鏈分析
  • 主要客戶及採購標準分析

促智藥市場:依形式分類

  • 介紹
  • 膠囊/錠劑
  • 粉末
  • 其他

促智藥市場:按分銷管道

  • 介紹
  • 離線
  • 線上

促智藥市場規模:依地區分類

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲 (MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲地區

競爭格局

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市場佔有率(2023年)

主要企業簡介

  • Onnit Labs, Inc.
  • Reckitt Benckiser Group PLC
  • Mental Mojo, LLC
  • NooCube
  • Mind Lab Pro(Performance Lab Group Ltd)
  • TruBrain
  • Zhou Nutrition
  • Kimera Koffee
  • Purelife Bioscience Co. Ltd.
  • Nootrobox Inc.
  • Nootropic Source
  • AlternaScript LLC
  • HVMN Inc.
  • Powder City LLC
  • Nootropics Depot LLC
  • Peak Nootropics
  • Nootropic Geek LLC
  • Mind Nutrition Ltd.
  • Neurofuse Inc.
  • BrainMD Health
簡介目錄
Product Code: SQMIG35A2160

Global Nootropics Market size was valued at USD 3.77 billion in 2022 and is poised to grow from USD 4.32 billion in 2023 to USD 12.87 billion by 2031, growing at a CAGR of 14.62% during the forecast period (2024-2031).

The nootropics market, encompassing a range of cognitive enhancers aimed at improving mental functions such as memory, creativity, and focus, is witnessing significant growth driven by increased consumer demand across various demographics. Both natural and synthetic compounds, including caffeine, ginseng, and modafinil, play a pivotal role in this space, functioning by enhancing blood flow to the brain, elevating neurotransmitter levels, and protecting neuronal health. Students, professionals, and athletes are increasingly drawn to these enhancements to optimize their cognitive performance; however, the long-term effects of certain nootropics remain uncertain, underscoring the importance of using these substances under medical supervision. In the U.S., multivitamin tablets also serve a dual purpose, as adults often turn to them for improved cognitive functions like concentration and alertness. The rising popularity of smart medications is reflected in trends reported in sources such as dualdiagnosis.org, highlighting a growing societal inclination toward enhancing mental capacity. This market expansion is further fueled by the widespread acceptance of smart pharmaceuticals among students and professionals alike, emphasizing the need for careful consideration when integrating cognitive enhancers into daily routines. Overall, the nootropics market represents a burgeoning sector with promising growth opportunities, driven by the increasing pursuit of mental acuity and productivity enhancement.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nootropics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nootropics Market Segmental Analysis

Global Nootropics Market is segmented by Form, Distribution Channel, and region. Based on Form, the market is segmented into Capsules/Tablets, Powder, Drinks, Others. Based on Distribution Channel, the market is segmented into Online, Offline. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nootropics Market

The global nootropics market is significantly driven by the escalating demand for cognitive enhancers, particularly among students and working professionals facing intense academic and occupational pressures. As competition rises, individuals increasingly seek solutions to enhance cognitive functions such as memory retention, creativity, and focus. Nootropics emerge as a viable option, offering benefits that boost brain performance and improve mental clarity, thereby enabling users to meet their demands effectively. Additionally, the rising prevalence of age-related cognitive decline among the elderly is further fueling market growth, as this demographic increasingly turns to nootropics to maintain cognitive health and enhance quality of life.

Restraints in the Global Nootropics Market

The global nootropics market faces significant restraints primarily due to the absence of standardization and regulatory oversight within the industry. Many nootropic substances lack approval from regulatory bodies, like the FDA, leading to heightened safety concerns among potential consumers. The unclear long-term effects of various nootropics exacerbate these apprehensions, deterring users from integrating them into their daily routines. Furthermore, inconsistencies in standardized dosages and quality control during manufacturing contribute to uncertainty regarding the effectiveness and safety of these products, undermining consumer confidence and hindering market growth in an increasingly health-conscious environment.

Market Trends of the Global Nootropics Market

The global nootropics market is poised for substantial expansion, driven by a rising appetite for cognitive enhancers from diverse demographics, including students, professionals, and the aging population. A notable trend is the increasing preference for natural and herbal nootropics as consumers prioritize health and wellness. As innovation fuels product development, companies are introducing cutting-edge supplements tailored to enhance cognitive function, further propelling market growth. However, this burgeoning sector faces challenges such as regulatory inconsistencies and a lack of standardization, which could undermine consumer trust and potentially hinder market progression in the near future.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Regulatory Landscape
  • Value Chain Analysis
  • Key Customer and buying Criteria Analysis

Nootropics Market, By Form

  • Introduction
  • Capsules/Tablets
  • Powder
  • Drinks
  • Others

Nootropics Market, By Distribution Channel

  • Introduction
  • Offline
  • Online

Nootropics Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Onnit Labs, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reckitt Benckiser Group PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mental Mojo, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NooCube
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mind Lab Pro (Performance Lab Group Ltd)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TruBrain
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zhou Nutrition
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kimera Koffee
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Purelife Bioscience Co. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nootrobox Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nootropic Source
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AlternaScript LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HVMN Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Powder City LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nootropics Depot LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Peak Nootropics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nootropic Geek LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mind Nutrition Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neurofuse Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BrainMD Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments